13: 40-year-old man with a persistent cough Flashcards
Causes of Chronic Cough
Common causes of persistent cough include:
»upper airway cough syndrome (UACS - previously called postnasal drip)
»vocal cord dysfunction
»asthma
»gastroesophageal reflux disease (GERD)
»medications such as angiotensin-converting enzyme inhibitors (ACE-inhibitors)
»tobacco-related cough
»post-infectious cough
»chronic obstructive pulmonary disease (especially the chronic bronchitis type)
»non-asthmatic eosinophilic bronchitis.
Serious, less common causes of persistent cough include:
»pulmonary conditions such as bronchogenic carcinoma of the lung, sarcoidosis and tuberculosis.
»cardiac conditions such as congestive heart failure.
Causes of Wheezing
Asthma is the most common cause of persistent cough and wheezing.
Other causes of wheezing to consider include:
Chronic obstructive pulmonary disease Congestive heart failure
Foreign body aspiration
Persistent bronchitis
Upper airway cough syndrome
Vocal cord dysfunction
PE
Co-morbid Conditions of Asthma, Conditions that may require treatment to improve the control of asthma include:
gastroesophageal reflux disease (GERD) obesity or overweight
obstructive sleep apnea
rhinitis or sinusitis
stress and depression
Symptoms of Acute Sinusitis
In acute sinusitis, the nasal discharge is opaque and mucopurulent, not clear. (Clear drainage may be associated with allergies).
Many viral upper respiratory infections will gradually worsen over the five days. To diagnose a patient with acute bacterial sinusitis, they should have symptoms for a minimum of seven to 10 days following a viral URI.
Nasal congestion or obstruction persisting for more than 12 weeks would be associated with chronic sinusitis, not acute sinusitis.
Symptoms of Chronic Sinusitis
According to the AAO-HNS updated guidelines (2015), patients with chronic sinusitis have similar symptoms to patients with acute sinusitis, but they last at least 12 weeks. They must have two of the following symptoms:
»nasal obstruction or congestion
»mucopurulent drainage (anterior, posterior or both)
»facial pain, pressure or fullness
»decreased sense of smell
They must also have signs of inflammation on physical examination or radiological studies that will be discussed later.
However, according to the AAAAI/ACAAI Practice Parameter Update (2014), some patients with chronic sinusitis may have “subtle” symptoms such as only a mild increase in nasal congestion.
Asthma and Aspirin
It is important to ask about about aspirin in particular, as 21% of adults who have asthma have aspirin-induced asthma and should avoid NSAIDs.
Physical Exam - Persistent Cough
Nose examination may show swollen nasal turbinates and pallor of the nasal mucosa consistent Nose with allergic rhinitis. Clear, watery nasal drainage may also be present in patients with allergic rhinitis
Eyes
The eye examination may show signs of allergic conjunctivitis.
Ears
The examination of the ears should be performed as part of the examination of a patient with nasal symptoms, but may be normal.
Sinuses
Percussing the frontal and maxillary sinuses may be useful in assessing sinus tenderness that may indicate the possibility of an acute or chronic sinus infection.
Throat
Throat examination may reveal erythema or streaking, which may be a clue that the patient has upper airway cough syndrome.
Neck
Examining the neck for lymphadenopathy may show signs of infection.
Chest/Lungs
The lung examination may show wheezing. However, the absence of wheezing does not rule out asthma or other cardiac or pulmonary conditions. The lung examination may also show rales or other lung abnormalities that are suggestive of congestive heart failure or pneumonia.
Cardiovascular
The cardiac examination could show extra heart sounds (S3 or S4), which would suggest congestive heart failure.
Abdomen
Examination of the abdomen is unlikely to be helpful in this patient.
Extremities
In examining the extremities, one can look for clubbing, cyanosis or edema. Clubbing is not a finding in patients with asthma, but if present, may be a sign of other pulmonary or cardiac conditions. Cyanosis is unlikely to be present in patients seen in the office setting, but if present, may indicate a hypoxic pulmonary or cardiac condition. If edema is present, it may be a sign of congestive heart failure.
Skin
The skin examination may show eczema, since eczema and asthma may coincide.
Mental status
Mood and affect may help you determine if there is underlying depression.
Establishing a Diagnosis of Asthma
- Episodic symptoms of airflow obstruction or hyperresponsiveness are present.
- This obstructive airflow is at least partially reversible.
- Alternative diagnoses are excluded.
Classifying Asthma Severity
frequency of symptoms frequency of nighttime awakenings frequency of short-acting beta2 agonist use for symptom control interference with normal activity FEV1 value FEV1/FVC ratio
Asthma Pathophysiology and Treatment
Pathophysiology
Asthma is a chronic inflammatory disease of the airways that involves many cells, in particular: mast cells, eosinophils, T lymphocytes, macrophages, neutrophils, and epithelial cells. This chronic inflammation leads to airway hyperresponsiveness and limitation of airway flow (obstruction). The persistence of inflammation can lead to airway edema. Long-term inflammation can lead to airway remodeling and permanent loss of lung function.
Treatment
Since inflammation is the primary pathologic mechanism in asthma, maintenance medication that reduces inflammation is first-line therapy.
If a patient is acutely wheezing, he or she may need quick-acting rescue medications that focus on bronchodilation and opening up the airways.
Long-Term Effects of Uncontrolled Asthma
>Airway remodelling >Inflammation >Mucous hypersecretion >Airway smooth muscle hypertrophy >Angiogenesis >Subepithelial fibrosis
The most concerning long-term effect is less reversibility of the airway obstruction with medication so it will be more difficult to control the patient’s asthma. This is why we want to treat patients early on with appropriate medication to control symptoms and prevent all of the long-term complications.
Suspected Asthma Management
For patients with chronic cough thought to be due to asthma, the American College of Chest Physicians (ACCP) recommends offering an inhaled bronchodilator and an inhaled corticosteroid.
Allergic Rhinitis Management
Oral antihistamine + Nasal corticosteroid
According to the National Asthma Education and Prevention Program Expert Panel Report 3 (2007), there are four key tasks in an initial evaluation of asthma including:
- Classify asthma severity.
- Assess the patient’s knowledge and skills for self-management.
- Identify and control environmental factors and comorbid conditions that may aggravate asthma.
- Offer appropriate medications.
Maintenance Medication for Moderate Persistent Asthma
High dose inhaled corticosteroids are reserved for severe asthma as the risk of adverse effects increase with dose. Inhaled corticosteroids are well-tolerated and safe at the recommended doses. To reduce the potential adverse effects of inhaled corticosteroids: spacers are recommended to reduce local side effects, patients are advised to rinse their mouths and spit after inhalation, and consider adding a long-acting beta agonist to a low- or medium-dose of inhaled corticosteroid rather than using a higher dose of corticosteroid.
Oral corticosteroids suppress, control, and reverse airway inflammation. However, side effects with chronic administration include among other things: osteoporosis, adrenal suppression, growth suppression, dermal thinning, hypertension, Cushing’s syndrome, cataracts, increased emotional lability, psychosis, peptic ulcer disease, atherosclerosis, aseptic necrosis of the bone, diabetes mellitus, and myopathy. Every effort, then, is given to minimizing systemic corticosteroid use and maximizing other modes of therapy. When oral corticosteroids are resorted to (for quick relief of symptoms in a moderate or severe asthma exacerbation), they are given for a short duration, and side effects are monitored. Multiple courses of oral systemic corticosteroids (more than three courses annually) should prompt re-evaluation of asthma management for the patient.
Leukotriene receptor antagonists may be used in conjunction with low-dose inhaled corticosteroids, but they are expensive. (There is a generic version of montelukast, but it can still be expensive.) A Cochrane review also revealed as additions to patients already on inhaled corticosteroids, a long-acting beta2 agonist inhaler improves symptoms and lung function, while preventing exacerbations, more effectively than leukotriene receptor antagonists. A recent study suggests the efficacy of using a leukotriene-receptor antagonist as monotherapy in the treatment of asthma, however, at this time, clinical guidelines for the management of asthma have not changed.
Theophylline may also be used in conjunction with low-dose inhaled corticosteroids, but is not used that often due to the difficulty in titrating the theophylline dose to the correct level. A meta-analysis demonstrated that salmeterol (a long-acting beta2 agonist) inhaler led to improved lung function and more symptom-free days and nights compared to theophylline.